GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.71 $5.41 Friday, 19th Apr 2024 AUPH stock ended at $4.99. This is 3.74% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.92% from a day low at $4.78 to a day high of $5.01.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
2021-03-22 $13.58 $13.69 $13.17 $13.27 3 571 153
2021-03-19 $13.63 $13.78 $13.39 $13.64 2 987 926
2021-03-18 $13.87 $14.12 $13.44 $13.56 6 456 715
2021-03-17 $13.72 $14.11 $13.51 $14.01 3 620 721
2021-03-16 $14.32 $14.50 $13.60 $13.83 4 543 288
2021-03-15 $13.87 $14.39 $13.77 $14.25 2 682 063
2021-03-12 $13.48 $13.79 $13.18 $13.76 2 688 779
2021-03-11 $13.25 $13.72 $13.15 $13.65 2 256 641
2021-03-10 $13.43 $13.51 $12.96 $13.11 2 665 562
2021-03-09 $13.06 $13.43 $13.00 $13.12 2 529 228
2021-03-08 $13.20 $13.27 $12.55 $12.72 3 401 129
2021-03-05 $13.38 $13.45 $12.01 $13.09 8 501 988
2021-03-04 $14.18 $14.40 $13.19 $13.41 6 332 448
2021-03-03 $14.35 $14.59 $14.05 $14.38 2 849 292
2021-03-02 $14.26 $14.63 $14.17 $14.42 1 756 170
2021-03-01 $14.02 $14.49 $13.89 $14.48 3 397 482
2021-02-26 $14.58 $14.87 $13.85 $14.00 4 783 388
2021-02-25 $15.00 $15.47 $14.16 $14.58 6 444 207
2021-02-24 $14.52 $14.73 $14.28 $14.58 3 322 351
2021-02-23 $15.00 $15.05 $13.81 $14.38 5 166 346
2021-02-22 $15.94 $15.95 $15.24 $15.27 2 873 941
2021-02-19 $16.00 $16.22 $15.84 $15.95 2 693 032
2021-02-18 $15.80 $16.15 $15.48 $15.87 2 284 021
2021-02-17 $15.51 $16.06 $15.19 $15.95 3 694 122
2021-02-16 $15.80 $15.80 $15.41 $15.65 2 244 945
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT